Read the full article here.
This content was originally published by BusinessLIVE. Original publishers retain all rights. It appears here for a limited time before automated archiving. By BusinessLIVE
Cipla plans to sell the drug at $55 a shot, or $330 (R5,600) for a five-day course, according to Cipla SA CEO Paul Miller.